Zydus Lifesciences Ltd on Thursday said it has received final approval from the U.S. health regulator to manufacture and market its generic Acetazolamide tablets used in the treatment of glaucoma.
The approval by the U.S. Food and Drug Administration is for Acetazolamide tablets of strengths 125 mg and 250 mg, Zydus Lifesciences said in a regulatory filing.
-
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI -
"I Am A Material Man In A Material World': Quantum Advisors' Ajit Dayal On NDTV Profit Ignite
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh, it said.
Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. It decreases the pressure in the eye, the company said.
It further said acetazolamide is also used to reduce the severity and duration of symptoms such as upset stomach, headache, shortness of breath, dizziness, drowsiness, and fatigue, of altitude sickness.
The drug is used with other medicines to reduce excess fluid retention and to help control seizures in certain types of epilepsy.
Acetazolamide tablets 125 mg and 250 mg had annual sales of 16 million in the US, the company said citing IQVIA MAT December 2022 data.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.